EQL Pharma Investor Relations Material
Latest events
Q1 25/26
EQL Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EQL Pharma
Access all reports
EQL Pharma AB engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. It specializes in the treatment of male infertility by proactive production and sale of medicines under its owned trademarks to end consumers, private actors as well as public hospitals and pharmacies. The company was founded in 2006 and is based in Lund, Sweden.
Key slides for EQL Pharma
CMD 2025
EQL Pharma
ABGSC Investor Days
EQL Pharma
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
EQL
Country
🇸🇪 Sweden